Effect of L-carnitine administration on the seminal characteristics of oligoasthenospermic stallions.
The effect of orally administered l-carnitine on the quality of semen obtained from stallions with different semen qualities was investigated. Four stallions with proven fertility (high motility group, HM) and with normal seminal characteristics (>50% progressive motility and > 80 x 10(6) spermatozoa/ml), and four questionable breeders (low motility group, LM) with <50% of sperm progressive motility and < 80 x 10(6) spermatozoa/ml, received p.o. 20 g of l-carnitine for 60 days. Blood and semen samples were collected before treatment (T0) and after 30 (T1) and 60 days (T2). Semen evaluation were performed on five consecutive daily ejaculates (n = 120 ejaculates) and conventional semen analysis was carried out on each ejaculate, both at collection and after refrigeration for 24, 48, and 72 h. Furthermore l-carnitine, acetylcarnitine, pyruvate, and lactate concentrations, and carnitine acetyltransferase activity (CAT) were determined both in raw semen and seminal plasma. There were an increase in progressive motile spermatozoa only in the LM group (26.8 +/- 12.9, 39.1 +/- 15.5, and 48.8 +/- 8.6 for T0, T1, and T2, respectively). Free seminal plasma carnitine concentration was higher in the LM group compared to the HM one. Both pyruvate and lactate were higher in the LM group. Raw semen and seminal plasma carnitine and acetylcarnitine levels correlate positively with both sperm concentration and progressive motility; moreover, acetylcarnitine content was positively correlated with total motile morphologically normal spermatozoa. In conclusion, oral administration of l-carnitine to stallions with questionable seminal characteristics may improve spermatozoa kinetics and morphological characteristics; whereas, it seem to be ineffective in normospermic animals.
Stradaioli
Giuseppe
G
Department of Animal Production Science, University of Udine, via delle Scienze 208, 33100 Udine, Italy. giuseppe.stradaioli@uniud.it
Sylla
Lakamy
L
Zelli
Riccardo
R
Chiodi
Pierino
P
Monaci
Maurizio
M
D000108:Acetylcarnitine / Q000032:analysis; D000818:Animals; D001947:Breeding; D002331:Carnitine / Q000008:administration & dosage* / Q000032:analysis; D002332:Carnitine O-Acetyltransferase / Q000032:analysis; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D007248:Infertility, Male / Q000188:drug therapy / Q000662:veterinary*; D019344:Lactic Acid / Q000032:analysis; D008297:Male; D019289:Pyruvic Acid / Q000032:analysis; D012661:Semen / Q000737:chemistry / Q000187:drug effects*; D013076:Sperm Count; D013081:Sperm Motility / Q000187:drug effects; D013094:Spermatozoa / Q000002:abnormalities / Q000187:drug effects / Q000648:ultrastructure
D019344:Lactic Acid; D000108:Acetylcarnitine; D019289:Pyruvic Acid; D002332:Carnitine O-Acetyltransferase; D002331:Carnitine